Drug recall · August 23, 2023
Tobramycin Opthalmic Solution USP recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Tobramycin Opthalmic Solution USP, 0.3%, 5mL bottle, Rx only, Manufactured for: Alembic Pharmaceuticals, Bedminster, NJ 07921, USA, NDC 62332-518-05
- Lots / codes
Lot #: AMR103, Exp: 10/2023; Lot#: AMR201, Exp: 06/2024
- Quantity
- 82,400 bottles
- Company
- Alembic Pharmaceuticals, Inc., Bedminster, NJ
- Distribution
- Nationwide in the USA
- Initiated
- July 27, 2023 · Voluntary: Firm initiated
- Classified
- August 17, 2023
- Reported
- August 23, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tobramycin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.